Has Timothy Smith, MD received payments from drug or device companies?

Yes. Drug and device makers reported $149,110 in general payments to Timothy Smith, MD across 210 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Timothy Smith, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Timothy Smith, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Timothy Smith, MD

Interventional Cardiology · Columbus, OHNPI 1982883344

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $119,500 of the $149,110 with a category attached, or 80.1%. Abiomed accounts for 89.9% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2020 at $45,853 and has fallen 89.6% since, to $4,753 in 2025. Among interventional cardiology clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$149,110in general payments, 2019–2025

Across 210 payments — averaging $710.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abiomed$134K
Boston Scientific$11K
Getinge USA Sales, LLC$2K
Medtronic$614
Abbott$417
Chiesi USA, Inc.$272
plus $495 from 9 others

$187,661in research payments, 2019–2025

Across 35 payments — averaging $5361.76 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Medtronic$157K
Shockwave Medical, Inc$13K
Abbott$9K
Procyrion, Inc.$8K

What the payments were for

Consulting fees$2,5002%
Speaking & faculty fees$119,50080%
Travel & lodging$19,64513%
Food & beverage$7,4535%
Education$120%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abiomed	119	$134,107
Boston Scientific	40	$10,879
Getinge USA Sales, LLC	12	$2,327
Medtronic(2 entities)	7	$614
Abbott	12	$417
Chiesi USA, Inc.	6	$272
Cardiovascular Systems Inc.	2	$152
AstraZeneca	1	$125
Biotronik Inc.	4	$64
Angiodynamics, Inc.	2	$51
Nuwellis, Inc.	1	$32
Cordis US CORP.	1	$31
Cardinal Health 200 LLC	1	$19
Johnson & Johnson	1	$14
Reflow Medical Inc	1	$7

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$149,110 in reported general payments places this provider in the 90th percentile of 256 interventional cardiology providers in Ohio.

See all interventional cardiology providers in Ohio →

Medicare billing

Part B allowed, 2024

$69,823

Medicare patients

194

Services billed

460

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	12	$13,816
ClopidogrelClopidogrel Bisulfate	80	$651
Metoprolol Succinate	22	$605
Atorvastatin Calcium	15	$200
Metoprolol Tartrate	11	$38

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Columbus

Gary AnselColumbus$3.3M
John CheathamColumbus$1.4M
Carlos Sanchez SotoColumbus$1.1M
Steven YakubovColumbus$907K
Mitchell SilverColumbus$562K
John PhillipsColumbus$410K
Michael JollyColumbus$281K
Christopher HuffColumbus$119K
Joseph CampbellColumbus$114K
Aref AmroColumbus$62K

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →